Skip to main content

American Thoracic Society

Events
Search
Sign Up
Sign In

Item Added to Cart

You just added

You have item(s) in your cart

  • Proceed to Checkout

REPLACE: (Riociguat rEplacing PDE5i therapy evaluated Against Continued PDE5i therapy): A Look at Phase IV Study Data

  • Overview
  • Resources

Thank you

This live web event has ended. Thank you for attending.

Description

This virtual learning session will review the clinical data from a recent Phase IV study.

This program is sponsored by Bayer Healthcare.

By registering for this webinar, you agree your information will be shared with the sponsor.

No CME or MOC credits are available for this program.

Opinions expressed and resources shared may not have been reviewed by the ATS prior to distribution through ATS channels, or reflect official positions of the ATS, unless it is explicitly noted as a result of official ATS approval. References to specific commercial entities (companies) or products do not reflect review or endorsement by the ATS unless it is explicitly noted as a result of official ATS approval.


Contributors

  • Ioana Preston, MD

    Pulmonary Function Lab Director; Director, Pulmonary Hypertension Center;
    Associate Professor, Tufts University School of Medicine

  • Prescribing Information

    http://labeling.bayerhealthcare.com/html/products/pi/Adempas_PI.pdf

September 1, 2021
Wed 6:30 PM EDT

Duration 1H 0M

This live web event has ended.

For Technical Support
support@blueskyelearn.com
+1 (858) 201-4136
Register
Log In
  • New
  • Existing

Forgot password?
  • Events
  • Search
  • Support
  • Sign Up
  • Sign In
  • Privacy Policy | Cookies Policy